# Trevi Therapeutics, Inc.: Form 8-K, filed Jun 13, 2024

- Company: [Trevi Therapeutics, Inc.](/companies/trvi.md) (CIK 1563880)
- Form: 8-K
- Filed: 2024-06-13
- Accepted by EDGAR: Jun 13, 2024, 17:01 ET
- Period: 2024-06-13
- Accession: 0000950170-24-073129
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1563880/000095017024073129/trvi-20240613.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1563880/000095017024073129/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1563880/000095017024073129/trvi-20240613.htm

Filed Jun 13, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-073129. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.